Evidence map›Paper›PMID 38849575›Full record

ArticleCell death and differentiation2024

The Caspase-Activated DNase drives inflammation and contributes to defense against viral infection.

Abdul Moeed, Nico Thilmany, Frederic Beck, Bhagya K Puthussery, Noemi Ortmann, Aladin Haimovici, M Tarek Badr, Elham Bavafaye Haghighi, Melanie Boerries, Rupert Öllinger and 12 more

Abstract read
In one paragraph

Article in Cell death and differentiation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Knockdown of caspase-activated DNase and B-cell lymphoma 2 inhibits cell proliferation and drug resistance in TP53-mutant multiple myeloma.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. The concealed side of caspases: beyond a killer of cells.Cellular and molecular life sciences : CMLS · 2024
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Abdul Moeed *Institute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0009-0002-3616-5520
Nico Thilmany *Institute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0003-1039-4173
Frederic BeckInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Bhagya K PuthusseryInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Noemi OrtmannInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Aladin HaimoviciInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0001-7455-7790
M Tarek BadrInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0002-8800-6380
Elham Bavafaye HaghighiInstitute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Melanie BoerriesInstitute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID 0000-0002-3670-0602
Rupert ÖllingerInstitute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center; TUM School of Medicine, Technical University of Munich, Munich, Germany.
Roland RadInstitute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center; TUM School of Medicine, Technical University of Munich, Munich, Germany.
Susanne KirschnekInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0001-7771-7817
Ian E GentleInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0002-6707-7809
Sainitin DonakondaInstitute of Molecular Immunology and Experimental Oncology, TUM School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0003-3216-8759
Philipp P PetricInstitute of Virology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Jonas F HummelInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Elisabeth PfaffendorfInstitute of Surgical Pathology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Paola ZanettaInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Christoph SchellInstitute of Surgical Pathology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Martin SchwemmleInstitute of Virology, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.
Arnim WeberInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany.ORCID 0000-0002-1723-6496
Georg HäckerInstitute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany. georg.haecker@uniklinik-freiburg.de.ORCID 0000-0003-1058-5746

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) MIRACUM-FKZ 01ZZ1801BDeutsche Forschungsgemeinschaft (German Research Foundation) 256073931-Z02Deutsche Forschungsgemeinschaft (German Research Foundation) 259373024-Z01Deutsche Forschungsgemeinschaft (German Research Foundation) 431984000-S1Deutsche Forschungsgemeinschaft (German Research Foundation) 441891347-S1
6 · The paper itself

Abstract

Mitochondria react to infection with sub-lethal signals in the apoptosis pathway. Mitochondrial signals can be inflammatory but mechanisms are only partially understood. We show that activation of the caspase-activated DNase (CAD) mediates mitochondrial pro-inflammatory functions and substantially contributes to host defense against viral infection. In cells lacking CAD, the pro-inflammatory activity of sub-lethal signals was reduced. Experimental activation of CAD caused transient DNA-damage and a pronounced DNA damage response, involving major kinase signaling pathways, NF-κB and cGAS/STING, driving the production of interferon, cytokines/chemokines and attracting neutrophils. The transcriptional response to CAD-activation was reminiscent of the reaction to microbial infection. CAD-deficient cells had a diminished response to viral infection. Influenza virus infected CAD-deficient mice displayed reduced inflammation in lung tissue, higher viral titers and increased weight loss. Thus, CAD links the mitochondrial apoptosis system and cell death caspases to host defense. CAD-driven DNA damage is a physiological element of the inflammatory response to infection.

Indexed as

DNA DamageInflammationMitochondriaAnimalsApoptosisCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDeoxyribonucleasesEndodeoxyribonucleasesHumansMiceMice, Inbred C57BLMice, KnockoutNF-kappa BNucleotidyltransferasesOrthomyxoviridae InfectionsPoly-ADP-Ribose Binding Proteinscaspase-activated deoxyribonucleasecGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDeoxyribonucleasesDffb protein, mouseEndodeoxyribonucleasesNF-kappa BNucleotidyltransferasesPoly-ADP-Ribose Binding Proteins

Identifiers

PMID38849575
PMCPMC11239672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.